Drug interactions with methadone;Interactions medicamenteuses avec la methadone

Presse Medicale

Volumn 28, Issue 25, 1999, Pages 1381-1384

  Schlatter, J ^a   Madras, J L ^b   Saulnier, J L ^b   Poujade, F ^b  

^a CENTRE HOSPITALIER DE GONESSE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CARBAMAZEPINE; CYTOCHROME P450; DISULFIRAM; FLUOXETINE; FLUVOXAMINE; INTERFERON; METHADONE; MU OPIATE RECEPTOR; OMEPRAZOLE; PHENOBARBITAL; PHENYTOIN; PSYCHOTROPIC AGENT; RIFAMPICIN; RITONAVIR; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ALCOHOLISM; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; HUMAN; LIVER MICROSOME; METHADONE TREATMENT; RESPIRATION DEPRESSION; REVIEW; WITHDRAWAL SYNDROME; ARTICLE; DRUG INTERACTION; DRUG THERAPY; METABOLISM;

ANTICONVULSANTS; ANTITUBERCULAR AGENTS; ANTIVIRAL AGENTS; DRUG INTERACTIONS; DRUG THERAPY; HUMANS; METHADONE; PHENYTOIN; PSYCHOTROPIC DRUGS; RIFAMPIN;

EID: 0033523326     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Parrino MW. First european conference on methadone. In: Drug addiction and related clinical problems, Tagliamonte A, Maremmani I., ed. Springer-Verlag, Wien, 1995, 213-18.
2. Beckett AH, Taylor JF, Casy AF, Hassan MMA. The biotransformation of methadone in man: synthesis and identification of a major metabolite. J Pharm Pharmacol 1968; 20:754-62.
3. Iribarne C, Berthou F, Baird S et al. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol 1996; 9:365-73.
4. Wu D, Otton SV, Sproule BA et al. Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone. Br J Clin Pharmac 1993; 35:30-4.
5. Eap CB, Bertschy G, Baumann P. High interindividual variability of nethadone enantiomer blood levels to dose ratios. Arch Gen Psychiatry 1998; 55:89-90.
6. Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM. Rifampin-induced methadone withdrawal. N Engl J Med 1976; 294:1104-6.
7. Raistrick D, Hay A, Wolff K. Methadone maintenance and tuberculosis treatment. BMJ 1996; 313:925-6.
8. Brown LS, Sawyer RC, Li R, Cobb MN, Colborn DC, Narang PK. Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users. Drug Alcohol Depend 1996; 43:71-7.
9. Tong TG, Pond SM, Kreek MJ, Jaffery NF, Benowirz NL. Phenytoin-induced methadone withdrawal. Ann Intern Med 1981; 94:349-51.
10. Liu SJ, Wang RIH. Case report of barbiturate induced enhancement of methadone metabolism and withdrawal syndrome. Am J Psych 1984; 141:1287-8.
11. Burger DM, Meenhorst PL, Napel CHH et al. Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactions. AIDS 1994; 8:1683-9.
12. Schwartz EL, Brechbülh AB, Kahl P, Miller MA, Selwyn PA, Friedland GH. Pharmacokinetic interactions of zidovudine and methadone in intravenous drug-using patients with HIV infection. J Acq Immune Def Syndr 1992; 5/6:619-26.
13. Hsu A, Granneman GR, Carothers L et al. Ritonavir does not increase methadone exposure in healthy volunteers. 5th Conference on Retrovirus and Opportunistic Infections, February 1-5, 1998, Chicago.
14. Bertshy G, Baumann P, Eap CB, Baettig D. Probable metabolic interaction between methadone and fluvoxamine in addict patients. Ther Drug Monit 1994; 16:42-5.
15. Eap CB, Bertschy G, Powell K, Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J Clin Psychopharmacol 1997; 17:113-7.
16. Bertschy G, Eap CB, Powell K, Baumann P. Fluoxetine addition to methadone in addicts: pharmacokinetic aspects. Ther Drug Monit 1996; 18:570-2.
17. Tommasello AC, Adir J. Alcohol and the steady-state disposition kinetics of methadone in rats. J Stud Alcohol 1984; 45:155-9.
18. Donnely B, Balkon J, Lasher C, dePaul Lynch V, Bidanset JH, Bianco J. Evaluation of the methadone-alcohol interaction. I. Alterations of plasma concentration kinetics. J Anal Toxicol 1983; 7:146-48.
19. Tong TG, Benowitz NL, Kreek MJ. Methadon-disulfiram interaction during methadone maintenance. J Clin Pharmacol 1980; 29:67-8.
20. Geber WF, Lefkowitz SS, Hung CM. Effect of morphine, hydromophone, methadone, mescaline, tryptan blue, vitamine A, sodium salicylate and caffeine on the serum interferon level in response to viral infection. Arch Int Pharmacodyn 1975; 214:322-7.
21. de Castro J, Aguirre C, Rodriguez-Sasiain JM, Gomez E, Garrido MJ, Calvo R. The effect of cnanges in gastric pH induced by omeprazole on the absorption and respiratory depression of methadone. Biopharm Drug Dispos 1996; 17:551-63.
22. Touzeau D, Gouravier L. Benzodiazépines et méthadone: liaison dangereuse ? Ann Med Interne 1994; 145:19-22.
23. Rogers WO, Hall MA, Brissie RM, Robinson CA. Detection of alprazolam in three cases of methadone/benzodiazepine overdose. J Forensic Sci 1997; 42:155-6.
24. Strain EC, Preston KL, Liebson IA, Bigelow GE. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone. J Pharmacol Exp Ther 1995; 272:628-38.